Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Dose Study to Investigate the Influence of Renal Insufficiency on the Pharmacokinetics of MK-7264
Conditions
Interventions
Gefapixant
Locations
2
United States
Clinical Pharmacology of Miami ( Site 0001)
Hialeah, Florida, United States
Orlando Clinical Research Center ( Site 0002)
Orlando, Florida, United States
Start Date
April 14, 2017
Primary Completion Date
September 3, 2017
Completion Date
September 13, 2017
Last Updated
July 27, 2022
NCT07262333
NCT01524276
NCT07203131
NCT02769975
NCT06660277
NCT06314503
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions